Sale!
Replica: Osimertinib EGFRm NSCLC Ex19Del/L858R Targeted Therapy
Replica: Osimertinib EGFRm NSCLC Ex19Del/L858R Targeted Therapy - Image 2

Replica: Osimertinib EGFRm NSCLC Ex19Del/L858R Targeted Therapy

Original price was: $577.00.Current price is: $418.00.

Osimertinib is a 3rd-generation irreversible EGFR-TKI, treats EGFRm NSCLC, targets EGFR Ex19Del or L858R mutations, and has CNS metastasis activity.,

SKU: SKU67EAI29VI Category:
Contact via Email Contact via WhatsApp
Guaranteed Safe Checkout

Osimertinib is a 3rd-generation irreversible EGFR-TKI, treats EGFRm NSCLC, targets EGFR Ex19Del or L858R mutations, and has CNS metastasis activity.,

Related products

Scroll to Top